Senior Marketing Operations Specialist

Redwood City, CA (On-site)

$115K/yr – $130K/yrSenior Level4+ years expFull time

Posted 3 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Coordinate global marketing assets and governance to keep brand, claims, and regulatory requirements aligned while juggling collateral, events, and vendor coordination.

  • Own collateral development, updates, and approval workflows across marketing, sales, and physician-education programs.
  • Manage asset libraries and distribution platforms to keep Showpad, Pepperflow, and digital content current and accessible.
  • Drive centralized brand governance with claims matrices and regulatory review to speed market execution.

Job Description

Responsibilities

  • The Senior Marketing Operations Specialist will support the development and management of global marketing collateral and help ensure compliance with Pulmonx brand standards, messaging, and applicable regulatory requirements.
  • Coordinate the development and updating of marketing and sales materials, presentations, and related collateral in partnership with internal stakeholders and external agencies.
  • Develop presentations and supporting materials for sales meetings, physician education programs, leadership meetings, and industry events.
  • Assist in the development and maintenance of graphics, promotional materials, and other marketing tools that support commercial initiatives.
  • Assist with the development of internal communications, newsletters, and event promotions as needed.
  • Manage stock photography resources and support the creation of Bitly links and QR codes for marketing materials.
  • Help maintain Pulmonx brand guidelines and support consistency across marketing materials and communications.
  • Maintain marketing claims matrices, approved FAQs, and related marketing documentation.
  • Support marketing expense tracking, invoice processing, purchase orders, and budget reporting activities, including forecast-to-actual tracking.
  • Coordinate printing, inventory management, and shipment of collateral materials and promotional items.

Requirements

  • Bachelor’s degree in Marketing, Communications, Business, or a related field.
  • 4–6 years of experience in marketing operations, communications, project coordination, or related roles.
  • Strong organizational skills with the ability to manage multiple projects and deadlines in a fast-paced environment.
  • Excellent written, editing, and verbal communication skills.
  • Ability to work cross-functionally and collaborate effectively with multiple stakeholders and external vendors.
  • Detail-oriented with strong project management and operational coordination capabilities.
  • Experience supporting marketing review processes, marketing material development, events, or operational workflows; experience in a regulated industry is preferred.
  • Familiarity with marketing, CRM, or project management platforms such as Salesforce, HubSpot, Asana, Basecamp, Showpad, or Pepperflow is preferred.
  • Proficiency in Microsoft Office and presentation development tools required; graphic design experience is a plus.
  • Ability to adapt quickly, prioritize competing needs, and support a wide range of marketing initiatives.

Preferred

  • Graphic design experience is a plus.
  • Familiarity with marketing, CRM, or project management platforms such as Salesforce, HubSpot, Asana, Basecamp, Showpad, or Pepperflow is preferred.
Pulmonx Corporation logo

Pulmonx Corporation

3.0 Glassdoor

Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1 Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death.11. Criner G et al AM J Resp Crit Care Med 2018, Published on 22-May-2018 as 10.1164/rccm.201803-0590OCBrief Statement: The Pulmonx Zephyr® Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. The Zephyr Valve is contraindicated for: Patients for whom bronchoscopic procedures are contraindicated; those with evidence of active pulmonary infection; known allergies to Nitinol (nickel-titanium) or its constituent metals (nickel or titanium); known allergies to silicone, or with large bullae encompassing greater than 30% of either lung; Patients who have not quit smoking. The Zephyr Valve should be used with caution and only after careful consideration in treating patients with: Prior lung transplant, LVRS, median sternotomy, or lobectomy; Congestive heart failure or recent myocardial infarction; FEV1 <15% of predicted value. Use is restricted to a trained physician. Prior to use, please reference the Zephyr Endobronchial Valve System Instructions for more information on indications, contraindications, warnings, all precautions, and adverse events.

Founded in 1998
Redwood City, California, USA
285 employees (8 in marketing)
35% recommend to a friend
49% CEO approval

Traffic Signals

Monthly Visitors
12.2K
Traffic Source Mix
Search
42.7%
Direct
41%
Referral
7.3%
Social
7%
Paid
1.8%

Headcount Trend

Current headcount: ~284

Marketing Team

Marketing Team Size
8 (3% of company)
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$276.9M
Last Raise
$66M
Series H, 6 years ago

Funding History

  • May 2020
    Series H • $66M
  • May 2020
    Debt Financing • $17M
  • May 2019
    Series G • $65M

Recent News